PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Partnership aims to boost mental health research

The University of Strathclyde, the NHS and New York University join forces to increase knowledge.

A significant collaboration involving the University of Strathclyde, the NHS and New York University hopes to galvanise mental health research and practice.

The ‘Mental Health Futures Collaborative’ (MHFC) has been duly created to bolster partnerships within the University of Strathclyde, across the NHS and the third sector, and with international universities. It includes a wider focus on mental health research, knowledge sharing and reducing mental health inequalities.

Ultimately, MHFC aims to strengthen evidence for the prevention of mental health problems and support policy change. It also intends to promote and develop digital technology for incorporation into mental health treatment in the future.

Furthermore, MHFC will be driven by the mental health experiences of individuals and informed by professionals from across the private and public sectors, along with those in the NHS, social care, occupational health and human resources.

There will also be representation from individuals working in student support services, while researchers from each of Strathclyde’s four faculties will also feature in the project.

Professor Victoria Stanhope, associate dean for faculty affairs at NYU Silver School of Social Work, explained: “We are delighted to be working with colleagues within Strathclyde to help us strengthen our collaborative research focused on mental health and vulnerable populations.”

She added: “We can draw important insights between some of the mental health challenges within our urban environment here in New York and those evident within Glasgow, we want to understand better ways to reduce mental health inequities.”

Dr Nicola Cogan, a senior lecturer in Strathclyde’s department of psychological sciences and health, is the University’s lead in the venture. She said: “MHFC is an exciting opportunity to bring together academics, practitioners and professional services staff working in mental health within Strathclyde, as well as external stakeholders and international collaborators, to strength our collaborative partnerships and leadership in mental health research and knowledge exchange.”

Lee Knifton, co-director of Strathclyde’s centre for health policy, concluded: “Our focus within the Collaborative is to be at the forefront of world-leading research and knowledge exchange with our international partners.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026